Research from an Imperial College London study and Scottish paper Early Pandemic Evaluation and Enhanced Surveillance of Covid-19, states that people with Omicron are 15 to 20 per cent less likely to need hospital treatment.
As per the State Health Department, all the samples were sent for genome sequencing at the Institute Of Life Sciences (ILS), Bhubaneswar.
The nationwide Omicron infection tally has increased to 1,525, of which 560 have been discharged from hospitals.
Of the total new positives, the maximum 177 cases were detected from Khordha, followed by 45 from Cuttack, 38 from Sundargarh, 15 from Jharsuguda. The lone death case from the virus infection was reported from Khordha district.
US continues to be the worst-hit country with the world's highest number of cases and deaths at 54,859,966 and 825,816, according to the CSSE.
Ganguly (49), who had undergone treatment for a heart condition early last year, was admitted to the hospital on December 28.
The eligible beneficiaries can register themselves for the vaccine jab on CoWin app or web portal and book their slots which will start from January 3, 2022. Besides, they can avail on-the-spot booking at the vaccination centers as well
Khurda, where Bhubaneswar is located, reported the maximum number of fresh cases at 119, followed by 35 in Cuttack. Thirty-three children are among those newly afflicted with the disease.
The second worst-hit country in terms of cases is India (34,838,804 infections and 481,080 deaths), followed by Brazil (22,291,839 infections and 619,334 deaths).
India saw 22,775 new infections being reported in a day, while the death toll climbed to 4,81,080 with 220 daily fatalities, the data stated.
In a separate tweet on Friday, Swaminathan said: "Hospitalisations are also rising, mostly in unvaccinated people. Though #Omicron may cause less severe disease, a small percent of a huge number is still very large & can overwhelm health systems".
Director of State Health Services, Bijay Mohapatra, on Friday, said that there has been no sign of community spread of the new mutant in Odisha so far.
Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. The vaccine is one of India's two main vaccines against Covid pandemic under mass vaccination drive.
Mishra said that a person is eligible to get the dose if the gap between the second dose of Covid vaccine and the registration date for the booster is more than 9 months (39 weeks).
The Special Relief Commissioner (SRC) has listed down the activities on which the night curfew restrictions will not be applicable.